This article was originally published in The Gray Sheet
Microwave technology manufacturer changes its name to Celsion to reflect the company's underlying purpose - to use focused heat technology to kill cancer cells. The firm recently filed an investigational device exemption with FDA to begin clinical studies of its microwave benign prostatic hyperplasia treatment system, which incorporates a microwave balloon catheter for transurethral microwave heating to shrink the prostate and compress the urethra wall. "The combination of microwave heat and balloon catheter compression creates a natural biological stent in the urethra, providing immediate relief of urinary obstruction," the company explains in an April 27 release
You may also be interested in...
Assessment work also isn’t slowing down, the new and generic drug office directors said in an interview, but approval data offers a note of concern.
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.